Charbonneau v. Boehringer Ingelheim Pharmaceuticals, Inc. and Pfizer, Inc.

Represented plaintiffs in first Mirapex products liability bellwether trial.  On July 30, 2008, jury returned a verdict in favor of plaintiffs for $8,279,300, including $7.8 million in punitive damages for failing to warn of risk of compulsive behaviors, including pathological gambling, from the Parkinson's drug Mirapex.  After the verdict, we engaged in settlement negotiations with the defendants and confidentially settled all of the firm's remaining Mirapex cases.  The firm represented more than 280 clients injured by Mirapex.